Current Drug Targets - Cardiovascular & Hematological Disorders
Continued as: Cardiovascular & Hematological Disorders-Drug Targets
Volume 5, 6 Issues, 2005
ISSN: 1568-0061 (Online)
ISSN: 1568-0061 (Print)
This journal supports open access
ISSN: 1568-0061 (Online)
ISSN: 1568-0061 (Print)
This journal supports open access
Contents
Current Drug Targets - Cardiovascular & Hematological Disorders , Volume 5 - Number 6
Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression
, 5(6): 431 - 432Paul Schoenhagen and Steven E. Nissen
DOI: 10.2174/156800605774962013
Animal Models of Atherosclerosis Progression: Current Concepts
, 5(6): 433 - 440A. C. McMahon, L. Kritharides and H. C. Lowe
DOI: 10.2174/156800605774962031
Cholesterol Absorption Blockade with Ezetimibe
, 5(6): 455 - 462Peter P. Toth and Michael H. Davidson
DOI: 10.2174/156800605774962086
Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase
, 5(6): 463 - 469Akira Miyazaki, Tomoko Kanome and Takuya Watanabe
DOI: 10.2174/156800605774962040
Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?
, 5(6): 481 - 488W. A. Van der Steeg, K. El-Harchaoui, J. A. Kuivenhoven and J. J.P. Kastelein
DOI: 10.2174/156800605774961997
Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis
, 5(6): 503 - 512T. J. Allen and K. A. Jandeleit-Dahm
DOI: 10.2174/156800605774962068
Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis
, 5(6): 513 - 525I. Gouni-Berthold and W. Krone
DOI: 10.2174/156800605774962022
Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
, 5(6): 527 - 532A. Zalewski, C. Macphee and J. J. Nelson
DOI: 10.2174/156800605774962103
Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases
, 5(6): 533 - 540Dennis Bruemmer and Ronald E. Law
DOI: 10.2174/156800605774961988
Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies
, 5(6): 557 - 564Todd C. Villines and Allen J. Taylor
DOI: 10.2174/156800605774962059
Webmaster Contact: info@benthamscience.net